Ignite Creation Date:
2024-05-05 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 9:51 AM
Study NCT ID:
NCT00699998
Status:
COMPLETED
Last Update Posted:
2013-05-07
First Post:
2008-06-16
Brief Title:
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Study Overview
Official Title:
A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects With Unstable AnginaNon-ST-Elevation Myocardial Infarction Who Are Medically Managed
Status:
COMPLETED
Status Verified Date:
2013-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRILOGY ACS
Brief Summary:
This study will evaluate the relative efficacy and safety of prasugrel and clopidogrel in a medically managed Unstable AnginaNon-ST-Elevation Myocardial Infarction UANSTEMI acute coronary syndrome ACS population that is patients who are not managed with acute coronary revascularization
Detailed Description:
Based upon the significant number of subjects with UANSTEMI ACS who are managed medically and their high risk for future cardiovascular events further exploration of novel treatment strategies for this population who are under-represented in large clinical trials is warranted Potential subjects will be those with a recent UANSTEMI event who are to be medically managed Eligibility for this study will be determined by both the timing of the medical management decision and by prior commercial clopidogrel treatment at the time of randomization The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes TRILOGY ACS Study will assess the efficacy and safety of prasugrel and aspirin compared to the current standard of care clopidogrel and aspirin for long-term treatment of medically managed UANSTEMI ACS subjects
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| H7T-MC-TABYb | OTHER | Eli Lilly and Company | None |